The future of pharmaceuticals: Artificial intelligence in drug discovery and development.
AI transforms drug discovery, enhancing efficiency and reducing costs. Key advancements in clinical trials and molecular generation. 💊🤖
![[Brain midline segmentation method based on prior knowledge and path optimization].](https://yesilscience.com/wp-content/uploads/2025/09/Brain-midline-segmentation-method-based-on-prior-knowledge-and-path-optimization.jpg)
[Brain midline segmentation method based on prior knowledge and path optimization].
Innovative brain midline segmentation using deep learning achieves DSC of 67.38, enhancing accuracy and continuity. 🧠📊
Advancements in Artificial Pancreas Technology for Diabetes Management
Advancements in artificial pancreas technology aim to enhance diabetes management through full automation and AI integration. 🤖💉
Decoding HIV Discourse on Social Media: Large-Scale Analysis of 191,972 Tweets Using Machine Learning, Topic Modeling, and Temporal Analysis.
HIV discourse on social media analyzed 191,972 tweets, revealing 63% focused on education. 📊💬
AI Technology Identifies Prostate Cancer Missed by Pathologists
AI technology can detect early prostate cancer missed by pathologists, identifying subtle tissue changes in biopsies. 🧬🔍
DNN-Based Noise Reduction Significantly Improves Bimodal Benefit in Background Noise for Cochlear Implant Users.
DNN noise reduction boosts speech recognition in bimodal CI users by 19% in noise. 📈👂
Poliomyelitis dynamics with fractional order derivatives and deep neural networks.
Exploring poliomyelitis dynamics through fractional-order models and deep neural networks reveals critical insights into disease transmission. 📊🦠
Beyond the Growth: A Registry-Based Analysis of Global Imbalances in Artificial Intelligence Clinical Trials.
Global AI Clinical Trials: 596 studies, 62 countries, 35.6% in China. Urgent need for equitable collaboration! 🌍🤖📊
Weekly Health & AI Digest – September 01, 2025
Here are the latest breakthroughs in health & AI (September 01, 2025 week) 🔹 Automated Mucormycosis Diagnosis from Paranasal CT Using ResNet50 and ConvNeXt Small. Automated mucormycosis diagnosis via CT scans shows 100% accuracy with ConvNeXt Small model. 🤖🦠 ——-...
Automated Mucormycosis Diagnosis from Paranasal CT Using ResNet50 and ConvNeXt Small.
Automated mucormycosis diagnosis via CT scans shows 100% accuracy with ConvNeXt Small model. 🤖🦠